Pharmacovigilance and Risk Management Strategies Conference

Featured

Want to learn more about Pharmacovigilance and Risk Management Strategies Conference? You've come to the right site!

To keep you at the forefront.

Short Course 1:

Reference Safety Information

Short Course 2:

Pharmacovigilance and Risk Management Planning

Short Course 3:

Introduction to Statistics in Pharmacovigilance

Short Course 1:

Reference Safety Information

Short Course 2:

Pharmacovigilance and Risk Management Planning

Short Course 3:

Introduction to Statistics in Pharmacovigilance

Stephen Knowles, MD, MRCP Chief Medical Officer
Halozyme Therapeutics, United States
Lesley Wise, PhD, MSc Managing Director
Wise Pharmacovigilance and Risk Management, Ltd, United Kingdom
Mariette Boerstoel-Streefland, MD, MBA, MS Senior Vice President, Worldwide Patient Safety Officer
Bristol-Myers Squibb Company, United States
Cheryl Campbell, MS Associate Director of Executive Operations/Outreach and Communications, OSE,CDER
FDA, United States
E. Stewart Geary, MD MD, Global Safety Officer
Eisai Co., Ltd., Japan
Lisa Melanie Harinstein, PharmD Team Leader, Division of Pharmacovigilance, FDA
FDA, United States
Jeremy Jokinen, PhD, MS Vice President and Head, Safety Evidence and Sciences
Bristol-Myers Squibb Company, United States
Annette Stemhagen, DrPH, PhD, FISPE Chief Science Officer
UBC, United States
Sarah Vaughan Head of Vigilance Operations
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Annette S. Williams, MBA, RPh Vice President, Pharmacovigilance
IQVIA, United States
Jo Wyeth, PharmD Associate Director for Postmarket Assessments, OMEPRM, OSE, CDER
FDA, United States
Stella Blackburn, MD, MA, MSc, FFPM, FISPE, FRCP Strategy
Consultant, United Kingdom
William Gregory, PhD Senior Director, Safety and Risk Management
Pfizer Inc, United States
Valerie E. Simmons, MD, FFPM Senior Medical Fellow, Global Patient Safety
Eli Lilly and Company Ltd, United Kingdom